News about Josep Dalmau

Characterisation of the post-acute stage of anti-NMDA receptor encephalitis

The study, published in the journal The Lancet Neurology, compares the cognitive and psychiatric symptoms of patients with those of schizophrenia and1

Clínic Barcelona

Research May 27 2022

IDIBAPS and EUROIMMUN sign a new agreement on research into neuronal inflammatory diseases

The IDIBAPS research group Pathogenesis of neuronal autoimmune diseases, led by Josep Dalmau, and the company EUROIMMUN Medizinische Labordiagnostika1

Clínic Barcelona

Research April 29 2022

The Lancet Neurology selects a study from the Clínic-IDIBAPS among the most relevant published during the 20-year history of the journal

The publication collects the latest advances in neurology since 2002 and in the commemoration of its twentieth anniversary highlights the guidelines1

Clínic Barcelona

Research March 10 2022

Researchers propose a new biomarker that may be key in the diagnosis of psychotic outbreaks

Researchers from the Hospital Clínic-IDIBAPS, the Research Institute of the Hospital de Sant Pau – IIB Sant Pan and the CIBERER confirm that the mole1

Clínic Barcelona

Research June 15 2021

Clínic-IDIBAPS researchers identify a new autoimmune encephalitis

For the first time it has been confirmed that some patients with autoimmune encephalitis of unknown origin produce autoantibodies against a subunit o1

2 2

page1
page2 , current page.

News about Josep Dalmau

Characterisation of the post-acute stage of anti-NMDA receptor encephalitis

IDIBAPS and EUROIMMUN sign a new agreement on research into neuronal inflammatory diseases

The Lancet Neurology selects a study from the Clínic-IDIBAPS among the most relevant published during the 20-year history of the journal

Researchers propose a new biomarker that may be key in the diagnosis of psychotic outbreaks

Clínic-IDIBAPS researchers identify a new autoimmune encephalitis

navigation between pages below

Subscribe to the Newsletter of Clínic